
Proto Labs Financial Ratios 2025-2009 | PRLB
Brief overview of Proto Labs's financial ratios
Ratios are assessed across five available annual reports in the 2020–2025 interval.
The latest available valuation ratios are P/E 73.86x (median 62.03x), EV/EBITDA 17.51x (median 27.89x), P/S 2.94x (median 2.05x). On average, this basket is 43.2% above its own five-year medians. The market is pricing in elevated future expectations.
Earnings yield calculated as 1/P/E is about 1.4%, showing current profit per unit of share price.
The latest available business-quality ratios are ROE 3.2%, ROA 2.8%, ROCE 3.7%. Efficiency ratios are restrained, with capital and assets producing modest returns.
On PEG (0.24x), valuation is restrained relative to growth, but one ratio cannot replace cash-flow and risk analysis.
The cash conversion cycle is 47.4 days versus 38.1 days initially. Turnover changed little.
Conclusion
Proto Labs's profile looks stretched: price anticipates improvement that current quality ratios do not yet confirm.
Annual Financial Ratios Proto Labs
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
73.9 | 62.0 | 55.9 | -8.6 | 41.5 | 111.3 | 44.9 | 43.2 | 56.2 | 32.1 | 30.7 | 39.7 | 56.2 | 40.4 | - | - | - |
P/S |
2.9 | 2.1 | 1.9 | 1.8 | 2.8 | 13.0 | 6.2 | 7.4 | 8.5 | 4.6 | 5.4 | 7.9 | 12.2 | 7.7 | - | - | - |
EPS |
0.9 | 0.7 | 0.7 | -3.8 | 1.2 | 1.9 | 2.4 | 2.8 | 1.9 | 1.6 | 1.8 | 1.6 | 1.4 | 1.0 | 0.8 | 0.4 | - |
EV (Enterprise Value) |
1.55 B | 1.01 B | 955 M | 937 M | 1.42 B | 5.64 B | 2.82 B | 3.3 B | 2.93 B | 1.34 B | 1.42 B | 1.63 B | 1.96 B | 950 M | 7.54 M | -6.1 M | -2.7 M |
EBITDA per Share |
2.46 | 2.22 | 2.51 | -2.14 | 2.93 | 3.46 | 4.12 | 4.29 | 3.4 | 3.01 | 3.13 | 2.79 | 2.34 | 1.76 | - | 1.75 | - |
EV/EBITDA |
26.3 | 18.2 | 14.5 | -16.0 | 17.5 | 60.0 | 24.7 | 27.9 | 31.7 | 16.4 | 17.0 | 22.5 | 32.9 | 22.8 | - | -0.3 | - |
PEG |
-0.91 | -0.72 | -0.66 | 0.24 | 52.59 | 36.03 | -2.71 | 0.93 | 2.85 | -3.38 | 2.93 | 2.53 | 1.56 | 7.92 | - | - | - |
P/B |
2.3 | 1.5 | 1.4 | 1.3 | 1.7 | 8.8 | 4.9 | 6.1 | 6.3 | 3.6 | 4.4 | 6.2 | 9.4 | 6.2 | - | - | - |
P/CF |
21.1 | 13.2 | 13.1 | 14.3 | 25.1 | 52.9 | 53.1 | 92.4 | 59.3 | 33.2 | 100.7 | 120.7 | 66.8 | 122.7 | - | - | - |
ROE % |
3.15 | 2.48 | 2.48 | -14.83 | 4.03 | 7.89 | 10.87 | 14.14 | 11.23 | 11.24 | 14.20 | 15.68 | 16.67 | 15.33 | - | -30.34 | - |
ROA % |
2.78 | 2.23 | 2.23 | -12.90 | 3.59 | 6.84 | 9.45 | 12.37 | 9.98 | 10.31 | 12.88 | 14.48 | 15.33 | 13.91 | - | - | - |
ROCE % |
3.73 | 2.97 | 4.05 | -14.04 | 4.87 | 9.29 | 12.75 | 15.70 | 15.21 | 15.80 | 20.06 | 22.52 | 23.69 | 21.68 | - | -44.13 | - |
Current Ratio |
8.5 | 10.1 | 10.0 | 7.7 | 9.3 | 7.5 | 5.0 | 4.1 | 3.8 | 6.7 | 5.3 | 5.8 | 8.0 | 7.8 | - | - | - |
DSO |
49.8 | 50.8 | 54.0 | 58.4 | 51.6 | 48.5 | 45.7 | 53.2 | 56.5 | 42.3 | 58.3 | 42.2 | 47.5 | 51.2 | - | - | - |
DIO |
16.5 | 17.1 | 17.6 | 17.9 | 16.5 | 17.6 | 16.5 | 17.8 | 27.3 | 25.9 | 32.5 | 27.8 | 30.7 | 33.8 | - | - | - |
DPO |
18.9 | 20.5 | 21.4 | 28.6 | 30.0 | 29.5 | 27.5 | 30.7 | 38.5 | 31.5 | 45.4 | 35.4 | 38.4 | 34.8 | - | - | - |
Operating Cycle |
66.3 | 67.8 | 71.6 | 76.3 | 68.1 | 66.1 | 62.2 | 71.0 | 83.8 | 68.2 | 90.8 | 70.0 | 78.2 | 85.0 | - | - | - |
Cash Conversion Cycle |
47.4 | 47.4 | 50.3 | 47.7 | 38.1 | 36.6 | 34.7 | 40.3 | 45.4 | 36.7 | 45.4 | 34.6 | 39.8 | 50.2 | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Proto Labs
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.38 | 0.34 | 0.3 | 0.19 | 0.15 | - | 0.29 | 0.18 | 0.21 | - | 0.31 | -0.01 | 0.1 | - | 0.14 | 0.09 | 0.19 | - | 0.17 | 0.47 | 0.14 | - | 0.55 | 0.47 | 0.52 | - | 0.63 | 0.6 | 0.58 | - | 0.77 | 0.68 | 0.67 | - | 0.5 | 0.46 | 0.46 | - | 0.45 | 0.41 | 0.41 | - | 0.47 | 0.45 | 0.4 | - | 0.4 | 0.43 | 0.4 | - | 0.35 | 0.34 | 0.33 | 0.3 | 0.28 | 0.22 | 0.28 | - | 0.23 | 0.19 | 0.21 |
EBITDA per Share |
0.81 | 0.75 | 0.72 | 0.57 | 0.55 | - | 0.7 | 0.59 | 0.62 | - | 0.46 | 0.27 | 0.49 | - | 0.27 | 0.24 | 0.66 | - | 1.34 | 0.63 | 0.52 | - | 1.55 | 1.13 | 0.93 | - | 1.64 | 1.29 | 1 | - | 1.65 | 1.29 | 1.04 | - | 1.24 | 0.95 | 0.83 | - | 1.13 | 0.87 | 0.72 | - | 1.07 | 0.94 | 0.74 | - | 0.9 | 0.81 | 0.65 | - | 0.75 | 0.64 | 0.52 | 0.41 | 0.47 | 0.37 | 0.52 | - | 0.73 | 0.63 | 0.69 |
ROE % |
4.26 | 3.49 | 3.36 | 2.93 | 3.03 | 2.49 | 3.65 | 2.53 | 2.26 | 1.49 | 1.98 | 1.13 | 1.80 | 1.41 | 2.00 | 3.06 | 3.21 | 2.59 | 4.88 | 6.25 | 6.86 | 6.41 | 9.27 | 9.75 | 10.44 | 8.27 | 12.14 | 12.66 | 13.23 | 10.58 | 13.45 | 12.20 | 11.47 | 8.13 | 11.29 | 11.23 | 11.42 | 8.78 | 12.56 | 12.97 | 13.34 | 10.54 | 14.45 | 14.79 | 15.03 | 11.84 | 16.03 | 16.19 | 15.98 | 12.18 | 16.90 | 16.98 | 16.20 | 16.56 | -15.27 | -41.93 | -68.55 | -72.83 | -27.11 | -22.38 | -23.33 |
ROA % |
3.75 | 3.08 | 2.99 | 2.64 | 2.72 | 2.24 | 3.25 | 2.25 | 1.99 | 1.30 | 1.74 | 1.27 | 1.84 | 1.50 | 2.86 | 2.43 | 2.82 | 2.28 | 4.25 | 5.43 | 5.95 | 5.55 | 8.04 | 8.47 | 9.07 | 7.19 | 10.58 | 11.04 | 11.56 | 9.26 | 11.81 | 10.75 | 10.15 | 7.23 | 10.12 | 10.16 | 10.40 | 8.05 | 11.48 | 11.82 | 12.14 | 9.56 | 13.17 | 13.55 | 13.83 | 10.94 | 14.79 | 14.92 | 14.71 | 11.20 | 15.48 | 15.50 | 14.74 | 15.02 | 19.55 | 22.93 | 27.53 | 23.65 | 8.81 | 7.27 | 7.58 |
ROCE % |
5.16 | 4.20 | 4.02 | 3.57 | 3.82 | 3.13 | 4.65 | 4.21 | 3.88 | 2.89 | 3.64 | 2.75 | 2.88 | 2.33 | 3.17 | 4.36 | 4.25 | 3.30 | 6.04 | 7.43 | 8.10 | 7.58 | 11.21 | 11.81 | 12.90 | 10.29 | 14.92 | 15.34 | 16.01 | 12.69 | 16.89 | 15.83 | 15.60 | 11.59 | 16.05 | 15.76 | 16.19 | 12.36 | 17.67 | 18.50 | 19.43 | 15.44 | 21.26 | 21.96 | 22.11 | 17.27 | 23.60 | 23.76 | 23.12 | 17.68 | 24.24 | 24.01 | 22.81 | 23.54 | -23.86 | -62.75 | -102.45 | -108.56 | -40.84 | -32.78 | -34.94 |
Current Ratio |
8.0 | 8.2 | 8.2 | 9.5 | 9.1 | 10.1 | 10.2 | 10.4 | 9.3 | 10.0 | 7.9 | 8.2 | 7.3 | 7.7 | 9.4 | - | 9.1 | 9.3 | 8.8 | 8.1 | 7.7 | 7.5 | 7.5 | 7.5 | 7.5 | 7.7 | 7.7 | 7.7 | 7.7 | 8.0 | 8.0 | 8.0 | 8.0 | 9.0 | 9.0 | 9.0 | 9.0 | 12.0 | 12.0 | 12.0 | 12.0 | 10.8 | 10.8 | 10.8 | 10.8 | 13.4 | 13.1 | 13.1 | 13.1 | 12.4 | 12.4 | 12.4 | 12.4 | 10.8 | 10.8 | 10.8 | 10.8 | - | - | - | - |
DSO |
55.2 | 53.5 | 52.5 | 51.3 | 50.8 | - | 51.0 | 54.0 | 53.8 | - | 53.6 | 57.0 | 55.8 | - | 30.2 | 30.9 | 61.0 | - | 61.5 | 58.6 | 52.1 | - | 49.1 | 49.5 | 45.7 | - | 44.6 | 45.2 | 46.9 | - | 46.8 | 49.2 | 46.9 | - | 53.3 | 57.3 | 48.7 | - | 39.8 | 41.5 | 44.1 | - | 48.6 | 51.5 | 47.0 | - | 40.5 | 41.8 | 42.1 | - | 39.8 | 42.1 | 41.7 | 42.9 | 44.4 | 48.1 | 38.4 | - | 39.1 | 43.8 | - |
DIO |
17.3 | 17.4 | 16.8 | 16.0 | 16.5 | - | 16.5 | 16.6 | 17.2 | - | 18.0 | 18.9 | 17.6 | - | 9.8 | 9.3 | 18.3 | - | 12.3 | 13.1 | 15.6 | - | 18.8 | 18.3 | 16.8 | - | 15.9 | 16.5 | 16.9 | - | 17.4 | 18.2 | 19.6 | - | 26.5 | 28.8 | 26.9 | - | 25.4 | 26.0 | 26.4 | - | 32.4 | 33.8 | 31.3 | - | 26.3 | 28.0 | 30.4 | - | 29.4 | 31.6 | 31.8 | 33.4 | 33.0 | 34.4 | 30.1 | - | 33.6 | 36.4 | - |
DPO |
23.5 | 22.3 | 20.3 | 19.3 | 20.6 | - | 20.6 | 20.6 | 20.0 | - | 22.0 | 24.0 | 23.6 | - | 11.3 | 11.5 | 28.6 | - | 31.8 | 32.9 | 30.1 | - | 31.5 | 30.8 | 28.1 | - | 26.5 | 27.5 | 28.6 | - | 30.0 | 31.5 | 30.5 | - | 37.3 | 40.6 | 35.6 | - | 30.9 | 31.6 | 34.6 | - | 45.2 | 47.1 | 42.2 | - | 33.5 | 35.6 | 38.4 | - | 36.7 | 39.5 | 36.5 | 34.4 | 34.0 | 35.5 | 32.9 | - | 39.2 | 42.5 | - |
Operating Cycle |
- | - | 69.3 | 67.3 | 67.3 | - | 67.5 | 70.7 | 70.9 | - | 71.5 | 75.8 | 73.4 | - | 40.0 | 40.2 | 79.3 | - | 73.9 | 71.7 | 67.7 | - | 67.9 | 67.9 | 62.5 | - | 60.5 | 61.7 | 63.7 | - | 64.1 | 67.5 | 66.4 | - | 79.8 | 86.1 | 75.6 | - | 65.2 | 67.4 | 70.6 | - | 81.0 | 85.3 | 78.3 | - | 66.8 | 69.8 | 72.5 | - | 69.2 | 73.7 | 73.5 | 76.3 | 77.4 | 82.5 | 68.5 | - | 72.7 | 80.2 | - |
Cash Conversion Cycle |
- | - | 49.0 | 48.0 | 46.7 | - | 46.9 | 50.1 | 50.9 | - | 49.5 | 51.9 | 49.9 | - | 28.7 | 28.8 | 50.7 | - | 42.1 | 38.8 | 37.6 | - | 36.4 | 37.1 | 34.4 | - | 34.0 | 34.2 | 35.1 | - | 34.2 | 36.0 | 35.9 | - | 42.5 | 45.5 | 40.0 | - | 34.3 | 35.9 | 36.0 | - | 35.8 | 38.2 | 36.1 | - | 33.3 | 34.2 | 34.2 | - | 32.5 | 34.2 | 37.1 | 41.9 | 43.4 | 47.1 | 35.6 | - | 33.5 | 37.7 | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company Proto Labs, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
Financial Ratios of other stocks in the Metal fabrication industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
|
Haynes International
HAYN
|
- | - | $ 766 M | ||
|
Уральская Кузница
URKZ
|
- | - | - | ||
|
Челябинский трубопрокатный завод
CHEP
|
- | - | - | ||
|
ЧЗПСН
PRFN
|
- | - | - | ||
|
Трубная металлургическая компания
TRMK
|
- | - | - | ||
|
Allegheny Technologies Incorporated
ATI
|
$ 187.44 | 3.05 % | $ 26 B | ||
|
SG Blocks
SGBX
|
- | - | $ 811 K | ||
|
Valmont Industries
VMI
|
$ 481.7 | 1.07 % | $ 9.54 B | ||
|
Insteel Industries
IIIN
|
$ 30.65 | 0.1 % | $ 597 M | ||
|
Ryerson Holding Corporation
RYI
|
- | - | $ 904 M | ||
|
Mueller Industries
MLI
|
$ 66.41 | -0.67 % | $ 7.27 B | ||
|
Highway Holdings Limited
HIHO
|
$ 0.88 | -10.21 % | $ 4.01 M | ||
|
Carpenter Technology Corporation
CRS
|
$ 519.66 | 3.17 % | $ 26.1 B | ||
|
Ampco-Pittsburgh Corporation
AP
|
$ 8.04 | -3.37 % | $ 162 M | ||
|
Mayville Engineering Company
MEC
|
$ 25.67 | -0.85 % | $ 525 M | ||
|
Northwest Pipe Company
NWPX
|
$ 123.08 | -2.99 % | $ 1.2 B |